X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4943) 4943
Book Review (495) 495
Publication (264) 264
Newsletter (27) 27
Conference Proceeding (8) 8
Magazine Article (8) 8
Book Chapter (5) 5
Dissertation (3) 3
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4277) 4277
humans (4092) 4092
ceftriaxone - therapeutic use (3111) 3111
male (2474) 2474
female (2128) 2128
anti-bacterial agents - therapeutic use (2068) 2068
ceftriaxone (1926) 1926
adult (1426) 1426
middle aged (1218) 1218
infectious diseases (1060) 1060
aged (915) 915
pharmacology & pharmacy (794) 794
child (768) 768
antibiotics (762) 762
microbiology (746) 746
treatment outcome (741) 741
adolescent (734) 734
ceftriaxone - administration & dosage (715) 715
cephalosporins - therapeutic use (623) 623
microbial sensitivity tests (605) 605
animals (589) 589
child, preschool (589) 589
infant (560) 560
abridged index medicus (531) 531
infections (511) 511
anti-bacterial agents - pharmacology (465) 465
drug therapy, combination (451) 451
ceftriaxone - pharmacology (444) 444
medicine, general & internal (421) 421
pediatrics (411) 411
anti-bacterial agents - administration & dosage (405) 405
children (375) 375
prospective studies (352) 352
cefotaxime - therapeutic use (345) 345
bacterial infections - drug therapy (340) 340
therapy (333) 333
aged, 80 and over (323) 323
gonorrhea - drug therapy (308) 308
drug therapy (299) 299
ceftriaxone - adverse effects (293) 293
health aspects (288) 288
risk factors (288) 288
immunology (287) 287
ceftriaxone sodium (282) 282
infection (279) 279
drug resistance (277) 277
retrospective studies (264) 264
ciprofloxacin (258) 258
diagnosis (255) 255
cephalosporins (250) 250
research (248) 248
antimicrobial resistance (243) 243
meningitis (243) 243
care and treatment (237) 237
lyme disease - drug therapy (237) 237
penicillin (237) 237
time factors (234) 234
antimicrobial agents (231) 231
diagnosis, differential (224) 224
pneumonia (221) 221
management (215) 215
young adult (215) 215
anti-infective agents - therapeutic use (214) 214
disease (214) 214
drug therapy, combination - therapeutic use (213) 213
drug resistance, bacterial (210) 210
infant, newborn (210) 210
cefotaxime - analogs & derivatives (208) 208
analysis (206) 206
ciprofloxacin - therapeutic use (203) 203
drug administration schedule (201) 201
bacteria (190) 190
neisseria gonorrhoeae - drug effects (187) 187
pharmacokinetics (187) 187
surgery (183) 183
epidemiology (182) 182
penicillins - therapeutic use (181) 181
injections, intravenous (179) 179
acute disease (174) 174
administration, oral (173) 173
anti-bacterial agents - adverse effects (173) 173
follow-up studies (173) 173
cefotaxime (172) 172
drug resistance, microbial (172) 172
hospitals (168) 168
mice (168) 168
internal medicine (167) 167
patients (166) 166
dosage and administration (165) 165
medicine & public health (164) 164
resistance (164) 164
azithromycin (161) 161
meningitis, bacterial - drug therapy (161) 161
doxycycline - therapeutic use (160) 160
mortality (160) 160
streptococcus pneumoniae - drug effects (160) 160
ceftriaxone - pharmacokinetics (159) 159
drug resistance in microorganisms (159) 159
gonorrhea (159) 159
susceptibility (159) 159
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4327) 4327
French (184) 184
Spanish (108) 108
German (95) 95
Japanese (77) 77
Italian (60) 60
Russian (28) 28
Turkish (21) 21
Polish (13) 13
Dutch (12) 12
Chinese (10) 10
Hebrew (9) 9
Danish (7) 7
Finnish (7) 7
Romanian (6) 6
Czech (4) 4
Hungarian (4) 4
Portuguese (4) 4
Bulgarian (3) 3
Korean (3) 3
Norwegian (2) 2
Swedish (2) 2
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2014, Volume 59, Issue 8, pp. 1083 - 1091
Background. Ceftriaxone is the foundation of currently recommended gonorrhea treatment. There is an urgent need for backup treatment options for patients with... 
Gemifloxacin | Neisseria gonorrhoeae | Gonorrhea treatment | Gentamicin | Azithromycin | INFECTIOUS DISEASES | CEFTRIAXONE | gemifloxacin | SUSCEPTIBILITY | RESISTANT NEISSERIA-GONORRHOEAE | GONOCOCCAL URETHRITIS | MICROBIOLOGY | azithromycin | IMMUNOLOGY | SEXUALLY-TRANSMITTED INFECTIONS | CEFIXIME | gonorrhea treatment | gentamicin | IN-VITRO ACTIVITY | Gastrointestinal Diseases - epidemiology | Naphthyridines - adverse effects | United States | Humans | Middle Aged | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Gastrointestinal Diseases - pathology | Adult | Female | Anti-Bacterial Agents - adverse effects | Gentamicins - adverse effects | Gentamicins - therapeutic use | Administration, Oral | Fluoroquinolones - therapeutic use | Treatment Outcome | Injections, Intramuscular | Gonorrhea - drug therapy | Fluoroquinolones - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Azithromycin - adverse effects | Neisseria gonorrhoeae - isolation & purification | Drug Therapy, Combination - methods | Azithromycin - therapeutic use | Naphthyridines - therapeutic use | Adolescent | Gastrointestinal Diseases - chemically induced | Care and treatment | Dosage and administration | Gonorrhea | Risk factors | Antimicrobial agents | Effectiveness | Drug therapy | Drug resistance | Product safety | Index Medicus | and Commentaries
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2009, Volume 49, Issue 11, pp. 1703 - 1710
Journal Article
Journal Article
Journal Article